首页> 外文期刊>Global Pediatric Health >Etonogestrel Implant—To Leave or Stay: A Case Series:
【24h】

Etonogestrel Implant—To Leave or Stay: A Case Series:

机译:Etonogestrel植入物-离开或停留:一个病例系列:

获取原文
       

摘要

Long-acting reversible contraception, which include etonogestrel subdermal hormonal implants, has high efficiency rates in preventing teen pregnancy. Although these numbers are increasing, teens have the lowest long-acting reversible contraception usage rate of any group, which the American Congress of Obstetricians and Gynecologists addressed with recommendations for Nexplanon placement for teens. The American Congress of Obstetricians and Gynecologists has recommended support for increased use and training of practitioners and pediatricians to gain momentum. Safety remains a concern as increased usage by practitioners and pediatricians may lead to more adverse outcomes. Despite the improvements to Nexplanon as a preloaded insertion device to prevent deep placement and malalignment, there are few known published adverse outcomes. Although different products, a review of the adverse outcomes reported with Norplant removal may closely reflect today’s concerns with Nexplanon. The 3 case studies in this arti...
机译:长效可逆避孕药,包括依托孕酮皮下激素植入物,在预防青少年怀孕方面具有很高的效率。尽管这些数字在增加,但青少年的长效可逆避孕使用率是所有人群中最低的,美国妇产科医生会议针对Nexplanon放置建议针对青少年。美国妇产科医生大会建议支持增加对从业者和儿科医生的使用和培训,以获取动力。安全仍然是一个问题,因为从业者和儿科医生的使用量增加可能会导致更多不良后果。尽管对Nexplanon进行了改进,使其可以预装插入装置以防止深度放置和错位,但已知的不良后果很少见。尽管产品不同,但对因去除Norplant而导致的不良后果进行的回顾可能紧密反映了当今对Nexplanon的担忧。本案例中的3个案例研究...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号